Psyence Biomedical Ltd. is dedicated to advancing psychedelic medicines formulated from botanical psilocybin. The firm is actively exploring natural psilocybin as a ...
PEX010 is a leading investigational drug candidate formulated from naturally sourced, botanical psilocybin. It is developed for use in psilocybin-assisted psychotherapy, specifically targeting the mental health needs of patients with incurable cancer undergoing palliative care.
Pain Points: Anxiety, depression, grief, and adjustment disorder associated with terminal cancer diagnoses.
Solutions: Psilocybin-assisted psychotherapy to improve the quality of life and mental health outcomes in palliative care settings.
Target Users: Healthcare institutions, palliative care clinics, and oncology patients requiring mental health support.
Supply Chain
In-house botanical cultivationLicensed GMP-compliant manufacturing facilitiesStrategic partnership with iNGENu Pty Ltd for clinical trials
NPX-5 is the subject of active Phase IIb clinical trials targeting adjustment disorder in palliative care, representing the company's commitment to advancing evidence-based, nature-derived therapeutic interventions.
Price Range: N/A (Clinical-stage)
Pain Points: Adjustment disorder and chronic stress in terminal/palliative patient populations.
Target Users: Clinical research centers, neurology specialists, and academic medical institutions.
Supply Chain
Controlled cultivation environmentsClinical research organizations (CROs)
Through a strategic alliance with PsyLabs, the company operates as a supplier of pharmaceutical-grade ibogaine, focusing on high-quality, regulated production for the burgeoning psychedelic medical market.
Price Range: N/A (B2B/Supply contract-based)
Pain Points: Lack of standardized, GMP-compliant, high-quality ibogaine supply for medical research.
Solutions: Supply chain security for entities conducting clinical trials or drug development involving ibogaine.
Target Users: Biopharmaceutical research firms, drug developers, and authorized healthcare facilities.
Supply Chain
PsyLabs manufacturing allianceGlobal distribution network for clinical-grade materials
